These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Botulinum neurotoxin X lacks potency in mice and in human neurons. Gregg BM; Matsumura T; Wentz TG; Tepp WH; Bradshaw M; Stenmark P; Johnson EA; Fujinaga Y; Pellett S mBio; 2024 Mar; 15(3):e0310623. PubMed ID: 38347673 [TBL] [Abstract][Full Text] [Related]
4. Botulinum and Tetanus Neurotoxins. Dong M; Masuyer G; Stenmark P Annu Rev Biochem; 2019 Jun; 88():811-837. PubMed ID: 30388027 [TBL] [Abstract][Full Text] [Related]
5. Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity. Fonfria E; Elliott M; Beard M; Chaddock JA; Krupp J Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29973505 [TBL] [Abstract][Full Text] [Related]
6. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip. Tehran DA; Pirazzini M Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471 [TBL] [Abstract][Full Text] [Related]
7. Progress in cell based assays for botulinum neurotoxin detection. Pellett S Curr Top Microbiol Immunol; 2013; 364():257-85. PubMed ID: 23239357 [TBL] [Abstract][Full Text] [Related]
8. The long journey of botulinum neurotoxins into the synapse. Rummel A Toxicon; 2015 Dec; 107(Pt A):9-24. PubMed ID: 26363288 [TBL] [Abstract][Full Text] [Related]
9. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain. Bagues A; Hu J; Alshanqiti I; Chung MK Pharmacol Ther; 2024 Jul; 259():108668. PubMed ID: 38782121 [TBL] [Abstract][Full Text] [Related]
10. Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics. Duchesne de Lamotte J; Perrier A; Martinat C; Nicoleau C Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299143 [TBL] [Abstract][Full Text] [Related]
11. Engineered botulinum neurotoxins as new therapeutics. Masuyer G; Chaddock JA; Foster KA; Acharya KR Annu Rev Pharmacol Toxicol; 2014; 54():27-51. PubMed ID: 24016211 [TBL] [Abstract][Full Text] [Related]
16. Differentiating Botulinum Neurotoxin-Producing Clostridia with a Simple, Multiplex PCR Assay. Williamson CHD; Vazquez AJ; Hill K; Smith TJ; Nottingham R; Stone NE; Sobek CJ; Cocking JH; Fernández RA; Caballero PA; Leiser OP; Keim P; Sahl JW Appl Environ Microbiol; 2017 Sep; 83(18):. PubMed ID: 28733282 [TBL] [Abstract][Full Text] [Related]
17. Strategies to design inhibitors of Clostridium botulinum neurotoxins. Cai S; Singh BR Infect Disord Drug Targets; 2007 Mar; 7(1):47-57. PubMed ID: 17346211 [TBL] [Abstract][Full Text] [Related]
18. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain. Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA mSphere; 2016; 1(1):. PubMed ID: 27303710 [TBL] [Abstract][Full Text] [Related]
19. Challenges in searching for therapeutics against Botulinum Neurotoxins. Pirazzini M; Rossetto O Expert Opin Drug Discov; 2017 May; 12(5):497-510. PubMed ID: 28271909 [TBL] [Abstract][Full Text] [Related]
20. Engineering of Botulinum Neurotoxins for Biomedical Applications. Webb RP Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29882791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]